United Bankers H1'25: We are still waiting for earnings growth to resume
22 augusti, 09:44
22 augusti, 09:44
UB's H1 report was clearly better than expected in terms of numbers. However, the earnings beat was largely due to performance fees, and changes in forecasts have remained minimal. We are still positive on the company's long-term outlook, but in the short term, there are few share price drivers as earnings are going in the wrong direction and the valuation is neutral. We revise our target price for UB to EUR 18.0 (was EUR 19.0) and reiterate our Reduce recommendation.
22 augusti, 09:44
UB's H1 report was clearly better than expected in terms of numbers. However, the earnings beat was largely due to performance fees, and changes in forecasts have remained minimal. We are still positive on the company's long-term outlook, but in the short term, there are few share price drivers as earnings are going in the wrong direction and the valuation is neutral. We revise our target price for UB to EUR 18.0 (was EUR 19.0) and reiterate our Reduce recommendation.
Analys
Nibes kvartal
Aktierekommendationer
Aktier
Analys
Nibes kvartal
Aktierekommendationer
Aktier
1 DAG %
Senast
Stockholmsbörsen
22 augusti, 18:27
Powell-tal gav bränsle åt börsen – OMXS30 upp 1,6%
Federal Reserve
22 augusti, 16:18
Börserna stiger på Powell-beskeden
Nvidia
22 augusti, 15:09
Svagt upp inför Powells tal – Nvidia ner i förhandeln
Samhällsbyggnadsbolaget i Norden
22 augusti, 14:30
SBB: Långsamt i rätt riktning
Aktierekommendationer
22 augusti, 13:55
Kepler: Köp Nibe och Novo Nordisk
OMX Stockholm 30
1 DAG %
Senast
2 689,35